Search - tctmd.com

Displaying 1 - 20 of 233

Sort: Relevancy | Date

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

Two Conduction-System Pacing RCTs Give Conflicting Results

News Daily News

Two Conduction-System Pacing RCTs Give Conflicting Results

March 20, 2026

Presentation THT 2026

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Presenter: Ryan J. Tedford

March 04, 2026

Presentation THT 2026

Response to left atrial to coronary sinus shunting in patients with heart failure and atrial fibrilllation

Presenter: JoAnn Lindenfeld

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT Abstracts 2026

Hemodynamic and Functional Impact of Coronary Sinus Reducer Versus Enhanced External Counterpulsation in Chronic Ischemic Heart Failure

Presenter: Nayana Bhandari

March 02, 2026

Q&A Lior Jankelson on AI Tools for Suspected ACS and More

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

February 10, 2026

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

News Conference News AHA 2025

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

November 17, 2025

Presentation TCT 2025

Lecture: Refractory Angina: Don’t Treat the Coronaries, Put in a Coronary Sinus Reducer

Presenter: Timothy D. Henry

October 28, 2025

Presentation TCT 2025

TCT 100: Patented Automated Device for Removal of Contrast From Coronary Sinus for the Prevention of Contrast Induced Nephropathy During Coronary Angiography or Intervention

Presenter: Mohammad Reza Movahed

October 27, 2025

Presentation TCT 2025

TCT 792: First-in-human experience with a novel self-expandable coronary sinus reducer for treating symptomatic epicardial and microvascular ischemic heart disease

Presenter: Francesco Giannini

October 26, 2025

Presentation TCT 2025

TCT 793: Sex Specific Outcomes of Treating Patients with Refractory Angina with the Coronary Sinus Reducer: One-year outcomes from the REDUCER-I Registry

Presenter: Stefan Verheye

October 26, 2025

Presentation TCT 2025

TCT 789: Efficacy and Safety of Coronary Sinus Reducer Implantation in Refractory Angina: A Systematic Review and Meta-Analysis. CSR implantation reduces angina severity and quality of life while maintaining low complication rates.

Presenter: Mohammad Reza Movahed

October 26, 2025

Presentation TCT 2025

TCT 791: Coronary Sinus Narrowing for the Treatment of Patients with Angina Caused by Microvascular Dysfunction

Presenter: Maayan Konigstein

October 26, 2025

Presentation TCT 2025

TCT 1831: Anomalous Right Coronary Artery From Left Coronary Sinus With Malignant Interarterial Course: A Case of Reversible Ischemia and Surgical Resolution

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 1622: Deflate Please! A Stubborn Sinus Reducer Balloon

Presenter: Marouane Boukhris

October 25, 2025

Presentation TCT 2025

TCT 1621: Coronary Sinus Reducer Implantation for Refractory Angina in an LVAD-Supported Patient With Ischemic Cardiomyopathy

Presenter: Aimane Mechroubi

October 25, 2025

Presentation TCT 2025

Evidence and Practice of Coronary Sinus Reducers: Early Impressions

Presenter: Shmuel Banai

October 25, 2025

Presentation TCT 2025

TCT 1666: A Potential Killer: Giant Aneurysm of Right Coronary Sinus

Presenter: Xue Li

October 25, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

August 13, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.